NEW YORK CITY — Almost a quarter of surveyed U.S. adults met criteria for generalized anxiety disorder (GAD), though the vast majority of them were
NEW YORK CITY — Treatment with ketamine was noninferior to electroconvulsive therapy (ECT) for major depressive disorder, two meta-analyses showed, though it was inferior for
Patients obtained nearly 100 million prescriptions through illegal online pharmacies in 2023, according to a report from the IQVIA Institute for Human Data Science. That
Investigational therapies may soon change the treatment landscape for chronic inflammatory demyelinating polyneuropathy (CIDP). “Despite the fact that we have some good standard-of-care therapies —
Updates to national guidelines for the management of hypertrophic cardiomyopathy (HCM) endorse cardiac myosin inhibitor use in certain cases, greenlight more intensive physical activity, and
All dogs coming into the U.S. from other countries must be at least 6 months old and microchipped to help prevent the spread of rabies,
Adding daily use of the investigational drug cytisinicline to behavioral support doubled abstinence rates in e-cigarette users attempting to quit, a randomized phase II trial
Vora is a practicing internal medicine physician and infectious disease epidemiologist, and a policy fellow at Conservation International. There is a health crisis expected to
Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. As Steward Ship Was Sinking, CEO
– Enable Injections, Inc. (“Enable”), a leader in wearable drug delivery technology, today announced an expanded partnership with Roche. – The collaboration leverages Enable’s expertise